GlobeNewswire: IlluminOss Medical Contains the last 10 of 25 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T11:04:10ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/02/26/1742655/0/en/IlluminOss-Medical-Launches-the-IlluminOss-Bone-Stabilization-System-for-Use-in-the-Treatment-of-Traumatic-and-Fragility-Fractures-in-the-U-S.html?f=22&fvtc=4&fvtv=43849IlluminOss Medical Launches the IlluminOss® Bone Stabilization System for Use in the Treatment of Traumatic and Fragility Fractures in the U.S.2019-02-26T15:00:00Z<![CDATA[The Company’s Innovative Fracture Repair Technology Provides a New and Compelling Solution for Fragility Fractures Associated with the Aging Population The Company’s Innovative Fracture Repair Technology Provides a New and Compelling Solution for Fragility Fractures Associated with the Aging Population]]>https://www.globenewswire.com/news-release/2018/09/13/1570552/0/en/IlluminOss-Medical-Receives-Clearance-to-Expand-Clinical-Indications-in-the-U-S.html?f=22&fvtc=4&fvtv=43849IlluminOss Medical Receives Clearance to Expand Clinical Indications in the U.S.2018-09-13T13:00:00Z<![CDATA[Secures FDA Clearance for the Treatment of Traumatic, Fragility, Pathological and Impending Fractures Secures FDA Clearance for the Treatment of Traumatic, Fragility, Pathological and Impending Fractures]]>https://www.globenewswire.com/news-release/2018/01/09/1286073/0/en/IlluminOss-Medical-Granted-FDA-Marketing-Clearance-for-the-IlluminOss-Bone-Stabilization-System.html?f=22&fvtc=4&fvtv=43849IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss® Bone Stabilization System2018-01-09T14:00:00Z<![CDATA[First De Novo Clearance by FDA’s Orthopedic Branch Granted to Company’s Novel Fracture Repair Technology First De Novo Clearance by FDA’s Orthopedic Branch Granted to Company’s Novel Fracture Repair Technology]]>https://www.globenewswire.com/news-release/2016/11/01/1102983/0/en/Preliminary-Data-Presented-from-First-U-S-Clinical-Trial-of-IlluminOss-Medical-s-Photodynamic-Bone-Stabilization-System.html?f=22&fvtc=4&fvtv=43849Preliminary Data Presented from First U.S. Clinical Trial of IlluminOss Medical's Photodynamic Bone Stabilization System 2016-11-01T14:00:00Z<![CDATA[<p>First U.S. Findings Presented by Dr. Richard Terek Support the Benefits of Applying Minimally Invasive System to the Treatment of Pathological Fractures Due to Metastatic Bone Disease</p> EAST PROVIDENCE, RI--(Marketwired - Nov 1, 2016) - IlluminOss Medical, a privately-held, commercial stage medical device company focused on minimally invasive orthopedic fracture repair, today announced that Richard Terek, M.D., presented the first preliminary data from its U.S. pivotal clinical trial at the recent Musculoskeletal Tumor Society (MSTS) Meeting in Detroit. The IlluminOss System is the world's only system of its kind which supports the treatment of fractures using patient-specific bone conforming intramedullary implants.]]>https://www.globenewswire.com/news-release/2016/07/18/1102981/0/en/IlluminOss-Medical-Completes-Enrollment-for-U-S-Clinical-Trial-Using-Groundbreaking-Photodynamic-Bone-Stabilization-System.html?f=22&fvtc=4&fvtv=43849IlluminOss Medical Completes Enrollment for U.S. Clinical Trial Using Groundbreaking Photodynamic Bone Stabilization System 2016-07-18T14:00:00Z<![CDATA[<p>Minimally Invasive System May Offer Significant Advantages to Surgeons Treating Impending and Pathologic Fractures Using Patient-Specific Implants</p> EAST PROVIDENCE, RI--(Marketwired - Jul 18, 2016) -  IlluminOss Medical, a privately-held, commercial stage medical device company focused on minimally invasive orthopedic fracture repair, today announced it has completed enrollment in its first U.S. clinical trial towards FDA approval of its IlluminOss System, the world's first and only system of its kind which supports the treatment of fractures using patient-specific intramedullary implants. Thirteen surgical sites around the country participated in the trial, which included 80 patients -- all with impending or pathologic fractures in the humerus due to metastatic carcinoma.]]>https://www.globenewswire.com/news-release/2016/02/18/1102979/0/en/IlluminOss-Medical-to-Exhibit-Its-Groundbreaking-Fracture-Repair-System-at-AAOS-2016.html?f=22&fvtc=4&fvtv=43849IlluminOss Medical to Exhibit Its Groundbreaking Fracture Repair System at AAOS 2016 2016-02-18T15:15:00Z<![CDATA[<p>Currently Executing on First U.S. Clinical Trial Towards FDA Clearance</p> EAST PROVIDENCE, RI--(Marketwired - Feb 18, 2016) -]]>https://www.globenewswire.com/news-release/2015/10/19/1102976/0/en/IlluminOss-Medical-to-Exhibit-Patient-Conforming-Fracture-Repair-Technology-at-German-Congress-of-Orthopaedics-and-Traumatology-DKOU-2015.html?f=22&fvtc=4&fvtv=43849IlluminOss Medical to Exhibit Patient-Conforming Fracture Repair Technology at German Congress of Orthopaedics and Traumatology (DKOU) 2015 2015-10-19T09:00:00Z<![CDATA[<p>Announces New Distribution Agreement With Orthovative in Germany</p> EAST PROVIDENCE, RI--(Marketwired - Oct 19, 2015) - IlluminOss Medical a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, will be exhibiting its groundbreaking IlluminOss System at the German Congress of Orthopaedics and Traumatology (DKOU) 2015 in Hall 2.2 Booth #43. IlluminOss' minimally invasive technology uniquely allows for virtually instantaneous fracture fixation utilizing a light-curable polymer, contained within a balloon catheter.]]>https://www.globenewswire.com/news-release/2015/10/14/1102974/0/en/IlluminOss-Medical-Appoints-Manny-Avila-as-Chief-Executive-Officer.html?f=22&fvtc=4&fvtv=43849IlluminOss Medical Appoints Manny Avila as Chief Executive Officer 2015-10-14T14:00:00Z<![CDATA[<p>Medical Device Industry Expert to Advance Business Strategy for Revolutionary Fracture Repair Technology</p> EAST PROVIDENCE, RI--(Marketwired - Oct 14, 2015) - IlluminOss Medical, a commercial-stage medical device company focused on minimally invasive orthopedic fracture repair, has named Manny Avila as its chief executive officer. Avila brings more than two decades of experience in medical device sales, operations and business management to IlluminOss. His proven leadership abilities will benefit the company as it continues to grow in global markets and move towards FDA approval domestically.]]>https://www.globenewswire.com/news-release/2015/08/31/1102971/0/en/IlluminOss-Medical-s-First-of-Its-Kind-Bone-Stabilization-System-Used-in-Treatment-of-Rhode-Island-Hospital-Patient.html?f=22&fvtc=4&fvtv=43849IlluminOss Medical's First-of-Its-Kind Bone Stabilization System Used in Treatment of Rhode Island Hospital Patient 2015-08-31T14:00:00Z<![CDATA[<p>Dr. Richard Terek Utilizes World's Only Minimally Invasive, Patient-Conforming Implant to Treat Patient With Impending Cancer Related Fracture</p> EAST PROVIDENCE, RI--(Marketwired - Aug 31, 2015) - IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopaedic fracture repair, today announced that its first patient at Rhode Island Hospital has been successfully treated under the care of Richard Terek, M.D., as part of its U.S. Lightfix clinical trial. The trial applies IlluminOss' groundbreaking approach to orthopedic fracture repair leveraging its proprietary bone stabilization technology to the treatment of impending and pathologic fractures in the humerus due to metastatic bone disease.]]>https://www.globenewswire.com/news-release/2015/07/21/1102967/0/en/IlluminOss-Medical-Appoints-Clive-Ridgwell-as-Vice-President-of-Sales.html?f=22&fvtc=4&fvtv=43849IlluminOss Medical Appoints Clive Ridgwell as Vice President of Sales 2015-07-21T14:00:00Z<![CDATA[<p>New Hire Will Advance the Commercialization Strategy for IlluminOss' Fracture Repair System Internationally</p> EAST PROVIDENCE, RI--(Marketwired - Jul 21, 2015) -  IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, today announced the appointment of Clive V. Ridgwell as vice president of sales. Ridgwell brings more than 30 years of commercial experience in medical device fields which he will apply to the further development of IlluminOss' product strategy in global markets. ]]>